Mutation of Residue 33 of Human Equilibrative Nucleoside Transporters 1 and 2 Alters Sensitivity to Inhibition of Transport by Dilazep and Dipyridamole
Open Access
- 1 January 2002
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 277 (1), 395-401
- https://doi.org/10.1074/jbc.m105324200
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Molecular Identification and Characterization of Novel Human and Mouse Concentrative Na+-Nucleoside Cotransporter Proteins (hCNT3 and mCNT3) Broadly Selective for Purine and Pyrimidine Nucleosides (System cib)Published by Elsevier BV ,2001
- Nucleoside transporter proteins: emerging targets for drug discoveryEmerging Therapeutic Targets, 2000
- Nucleoside transporters: molecular biology and implications for therapeutic developmentMolecular Medicine Today, 1999
- Adenosine transport: Recent advances in the molecular biology of nucleoside transporter proteinsDrug Development Research, 1998
- Nucleoside transport and its significance for anticancer drug resistanceDrug Resistance Updates, 1998
- Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridineMolecular Membrane Biology, 1998
- Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1)American Journal of Physiology-Cell Physiology, 1997
- Nucleoside and nucleobase transport systems of mammalian cellsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1996
- Primary Structure and Functional Expression of a cDNA Encoding the Bile Canalicular, Purine-specific Na+-Nucleoside CotransporterPublished by Elsevier BV ,1995
- The cardiac effects of adenosineProgress in Cardiovascular Diseases, 1989